Dapagliflozin + MetFormin HCI
Daplozmet 5/850mg Tablet: Each film-coated tablet contains.
Dapagliflozin (as Dapagliflozin Propanediol Monohydrate) 5mg
Metformin Hydrochloride 850mg
Daplozmet 5/1000mg Tablet: Each film coated tablet contains Dapagliflozin (as Dapagliflozin Propanediol Monohydrate) 5mg
Metformin Hydrochloride 1000mg
Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor indicated for managing diabetes mellitus type 2. When combined with diet and exercise in adults, dapagliflozin helps to improve glycemic control by inhibiting glucose resorption in the proximal tubule of the nephron and causing glycosuria.
Daploz/Daplozmet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease or multiple cardiovascular risk factors Daploz/Daplozmet is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Daplozmet 5/850 mg tablets: Alu. Alu. blister pack of 2 x 7’s. Daplozmet 5/1000 mg tablets: Alu. Alu. blister pack of 2 x 7’s.